NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,813.30+₹52.30 (+2.97%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
Loading market information…
NSE · BAFNAPH.NS · INR
Stock price, earnings
Quote as of Oct 30, 2026, 06:44 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Bafna Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 6.55% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bafna Pharmaceuticals Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,813.30+₹52.30 (+2.97%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
₹9,810.50+₹146.50 (+1.52%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.35% below the high.
₹4,637.40+₹57.40 (+1.25%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 11.68% below the high.
₹136.08-₹0.46 (-0.34%)
ZIM Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 14.85% below the high.
₹128.33+₹0.00 (0.0%)
Valiant Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 9.23% below the high.
₹10.07-₹0.26 (-2.52%)
Nectar Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 55.04% below the high.
₹62.40-₹1.44 (-2.26%)
Brooks Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 46.21% below the high.
₹18.67-₹0.31 (-1.63%)
Medico Remedies Limited’s quoted price sits in the lower half of its reported 52-week range, 67.18% below the high.
